STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Nautilus Biotechnology, Inc.

Filed

June 17, 2024

Period of Report

June 14, 2024

Accession Number

0001062993-24-012727